Cargando…

Pediatric vitamin D: Pseudo‐hypervitaminosis

BACKGROUND: Vitamin D toxicity is rare in pediatric population. Falsely elevated levels of 25‐hydroxyvitamin D have been reported as a major challenge with immunoassay methods for quantifying vitamin D metabolites. CASE PRESENTATION AND METHOD: Here, we present two pediatric cases of falsely elevate...

Descripción completa

Detalles Bibliográficos
Autores principales: Olayinka, Lily, Poventud‐Fuentes, Izmarie, Garnett, Emily, Devaraj, Sridevi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492448/
https://www.ncbi.nlm.nih.gov/pubmed/37526221
http://dx.doi.org/10.1002/jcla.24950
Descripción
Sumario:BACKGROUND: Vitamin D toxicity is rare in pediatric population. Falsely elevated levels of 25‐hydroxyvitamin D have been reported as a major challenge with immunoassay methods for quantifying vitamin D metabolites. CASE PRESENTATION AND METHOD: Here, we present two pediatric cases of falsely elevated 25‐hydroxyvitamin D that resulted in unnecessary further testing. We also report significant same‐day variation in the measurement of 25‐hydroxyvitamin D using the Abbott i2000SR immunoassay. Samples were spun twice and their values were confirmed with the gold standard liquid chromatography‐tandem mass spectrometry (LC–MS/MS) method for confirmation. CONCLUSION: The addition of a centrifugation step prior to sample testing resolved the variation observed in the measurement of 25‐hydroxyvitamin D levels. The patient samples were confirmed with instruments from a different vendor and LC–MS/MS. Re‐centrifugation of samples resolved the variation in the 25‐hydroxyvitamin D values.